$ACLX News

Legend Biotech: Undervalued Leader In The CAR-T Race

Assessing Arcellx (ACLX) Valuation After Strong Multi Period Share Price Momentum

Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?

Arcellx President Sells $10M Worth of Shares After Acquisition Announcement

Guggenheim Downgrades Arcellx to Neutral, Lowers Price Target to $115

Gilead Snaps Up Arcellx For $115 Per Share — A $7.8 Billion Bet On Cancer Therapy

Truist Securities Downgrades Arcellx to Hold, Lowers Price Target to $120

Evercore ISI Group Downgrades Arcellx to In-Line, Maintains Price Target to $115

This Novo Nordisk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Citigroup Downgrades Arcellx to Neutral, Raises Price Target to $115

Leerink Partners Downgrades Arcellx to Market Perform, Announces $115 Price Target

Stifel Downgrades Arcellx to Hold, Lowers Price Target to $115

Let's take a look at the stocks that are in motion in today's session.

Here are the top movers in Monday's session.

These stocks are gapping in today's session

Dow Tumbles Over 700 Points; Dominion Energy Posts Upbeat Earnings

Gilead: Downgrade To 'Hold' Rating Despite Arcellx Acquisition

These stocks are moving in today's pre-market session

HC Wainwright & Co. Downgrades Arcellx to Neutral, Maintains Price Target to $115

Baird Downgrades Arcellx to Neutral, Raises Price Target to $115